Nav: Home

Breast cancer cells rely on pyruvate to expand in new tissues

March 04, 2019

Most patients who die of breast cancer die of metastasis, the process by which cancer cells spread to other organs of the body. Cancer cells alter their metabolism to grow and expand across other organs. A new study by Prof. Sarah-Maria Fendt from the VIB-KU Leuven Center for Cancer Biology and her PhD student Ilaria Elia has shown that breast cancer cells require the nutrient pyruvate to do this.

When cancer cells spread to different organs, and in particular to the lungs, they first need to reshape the healthy lung environment into a so-called metastatic niche that supports the growth of cancer cells. The enzyme that cancer cells need to activate this process is called collagen prolyl 4 hydroxylase. Until now, it was believed that the activity of this enzyme is regulated in both cancer and healthy cells by the amount of enzyme present. In other words, it is thought that if a lot of the enzyme is present its activity is high and vice versa. Since collagen prolyl 4 hydroxylase also has important functions in healthy cells, collagen prolyl 4 hydroxylase is a difficult cancer drug target because this would target cancer as well as healthy cells.

Prof. Sarah-Maria Fendt from the VIB-KU Leuven Center for Cancer Biology and her PhD student Ilaria Elia have now discovered that breast cancer cells that reach the lung require the nutrient pyruvate to restructure the healthy lung environment so that cancer cells can grow into metastasis. Specifically, pyruvate drives the production of a small molecule called α-ketoglutarate. This small molecule regulates the activity of collagen prolyl 4 hydroxylase independently of the amount of this enzyme. Importantly, only cancer cells or cells supporting the spread of cancer cells to distant organs seem to rely on this pyruvate-dependent mechanism to create a pro-tumor environment in the lung. This means that inhibiting pyruvate uptake by breast cancer cells, is sufficient to greatly impair metastasis formation in different breast cancer mouse models.

Interestingly, in an independent study Prof. Geert Carmeliet and Dr. Steve Stegen (Lab of Clinical and Experimental Endocrinology, KU Leuven) have investigated how normal bone cells create a healthy environment using collagen prolyl 4 hydroxylase. They found that bone cells also require α-ketoglutarate to regulate the activity of collagen prolyl 4 hydroxylase resulting in normal bone development and regeneration. But differently to cancer cells, normal bone cells do not rely on pyruvate, but the nutrient glutamine for this important function. Currently, mouse models already exist to target cancer cells without harming healthy cells and vice versa by selectively changing the uptake of pyruvate or glutamine.

Overall, these two studies indicate that healthy and cancer cells use different nutrients to shape their environment. This novel insight can be used to develop new therapies that specifically target breast cancer cells that have spread to the lung, while sparing healthy cells.
-end-


VIB (the Flanders Institute for Biotechnology)

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...